Previous studies have demonstrated familial clustering of prostate cancer. To define the nature of this familial aggregation and to assess whether Mendelian inheritance can explain prostate cancer clustering, proportional hazards and segregation analyses were performed on 691 families ascertained through a single prostate cancer proband. The proportional hazards analyses revealed that two factors, early age at onset of disease in the proband and multiple affected family members, were important determinants of risk of prostate cancer in these families. Furthermore, segregation analyses revealed that this clustering can be best explained by autosomal dominant inheritance of a rare (q = 0.0030) highrisk aflele leading to an early onset of prostate cancer. The estimated cumulative risk of prostate cancer for carriers revealed that the allele was highly penetrant: by age 85, 88% of carriers compared to only 5% of noncarriers are projected to be affected with prostate cancer. The best fitting autosomal dominant model further suggested that this inherited form of prostate cancer accounts for a significant proportion of early onset disease but overall is responsible for a small proportion of prostate cancer occurrence (9% by age 85). These data provide evidence that prostate cancer is inherited in Mendelian fashion in a subset offamilies and provide a foundation for gene mapping studies of heritable prostate cancer. Characterization of genes involved in inherited prostate cancer could provide important insight into the development of this disease in general.
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Molecular approaches to the understanding of human neoplastic disease have revealed that multiple genetic alterations are an essential component of tumorigenesis (1, 2) . Both inherited and somatic genetic alterations can be involved in the malignant transformation of normal cells (3) . Identification of the genes involved in neoplastic transformation has been approached through the molecular analysis of sporadic cancers and the genetic study of families with an inherited predisposition for cancer. The interplay of these two approaches has led to the characterization of genes such as the retinoblastoma gene, the p53 gene, and the APC gene that are each involved in the development of both hereditary, and nonhereditary forms of cancer (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . Because inherited and noninherited cancers can share common genetic lesions, the study of inherited cancer syndromes can provide insights into understanding the development of cancer in general.
Prostate cancer is the most common cancer diagnosed and the second leading cause of cancer mortality in United States men (16) . As with breast, colon, and other cancers for which Mendelian syndromes have been described and susceptibility genes have been mapped and cloned (14, 15, 17) , family history is known to be a risk factor for prostate cancer (18) (19) (20) (21) , which raises the possibility that transmissible genetic factors may be involved in the development of this disease in a subset of men. The genetic contribution to diseases of complex origin such as cancer is often most salient in the families of early onset cases (22) . Therefore, if prostate cancer is ever inherited in simple Mendelian fashion, it is most likely to be in the families with cases ofearlier onset. In this study, Kaplan-Meier and Cox proportional hazards analyses were performed to assess whether there was clustering of prostate cancer in families of probands with early disease onset. In addition, a segregation analysis of 691 prostate cancer families was done to test the hypothesis of a Mendelian form of prostate cancer. Should such a Mendelian subtype of prostate cancer exist, it is a likely object for gene mapping studies and could serve as a useful model for understanding genetic alterations underlying prostatic tumorigenesis in general.
METHODS
Families. Families were ascertained through 740 consecutive probands undergoing radical prostatectomy for primary clinically localized prostate cancer at The Johns Hopkins Hospital, Baltimore, between 1982 and 1989. Cases were not selected for family history of disease. The mean age at onset of prostate cancer in these probands was 59.3 years (SD = 6.5 years). The median age at onset in the general population of U.S. Caucasian men diagnosed with prostate cancer is 73.5 years (23). The younger age at onset of the probands in this study reflects the fact that the cohort does not include men with metastatic disease or other age-related health problems that would preclude surgical intervention. Ninety-six percent of the probands were Caucasian; additional demographic characteristics of this sample are described elsewhere (18) . In 1989, 691 probands were interviewed by telephone regarding family history of cancer. Probands were asked to recall cancer histories among fathers, brothers, uncles, and grandfathers. Positive family histories among first-degree relatives were validated in a sample of the reported cases by medical record review and found to be accurate (18) . Negative family histories were not validated. Review of the family histories revealed that information was most complete on first-degree relatives (fathers and brothers) with substantial underreporting of prostate cancer among more distant relatives (18) . Thus, only nuclear families are included in our analyses.
Proportional Hazards Analyses. Age-specific KaplanMeier estimates of cumulative prostate cancer risk were calculated for groups of relatives stratified by age at onset of disease in the family proband (<53 years, 53-65 years, and >65 years). These groupings allowed a comparison of risk in families ofprobands in the lowest quintile of age at onset (<53 years) to that of families of probands in the highest quintile (>65 years) of age at onset among these 691 probands. Differences in these Kaplan-Meier curves were assessed with the log-rank test. In addition, a Cox proportional hazards model was used to estimate hazard rates for probands'-Abbreviation: df, degree(s) of freedom.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (25, 26) . By constraining the parameters that describe the transmission of these types within families, one can specifically test the ability of genetic and nongenetic hypotheses to explain an observed phenotypic distribution in a set of family data.
In the present study, class A regressive models (24) as implemented in the REGTL module of the S.A.G.E. computer package (27) were used for analysis. The REGTL module permits segregation analysis of a truncated (censored) trait, such as age at onset of prostate cancer. Under this model, a proportion (y) of the population with the potential to develop prostate cancer is deemed susceptible. As prostate cancer is sex-limited, y was fixed at 0.0 for females in all analyses. Age at onset of prostate cancer is assumed to follow a logistic distribution described by two parameters, a and A, with the following probability distribution function: Jlage) = [aeW`+a*')]/(1 + e(A+a*age))2 (28) . This symmetric distribution is similar to a normal distribution and has a mean, -e3/a, and variance, r2/3a2. The cumulative distribution function is given by F(age) = y*antilogit(B + a*age) and represents the probability that a person will be affected by a given age.
Under the REGTL model used in the present analysis, the phenotype is the age at onset and the parameter is typedependent. This model allows the high-risk allele to influence the average age at onset for each type and, through this, the proportion of each type affected by a given age. In a common disease with late age at onset such as prostate cancer, low-risk individuals have a shifted age at onset distribution such that most will not be affected in the average lifetime. This model has been suggested (29) as appropriate for segregation analyses of common diseases with variable age of onset such as cancer.
The influence of genetic susceptibility was tested by considering three types of individuals (AA, AB, and BB) with three corresponding transmission parameters (rAA, TAB, and TBB) describing the probability of a parent of a given type transmitting the disease-producing factor A to offspring (30, 31) . Under hypotheses ofgenetic transmission ofdisease, the parameters are constrained to Mendelian values of TAA = 1-0, TAB = 0.5, and TBB = 0.0 that correspond to the probability that a parent of genotype AA, AB, and BB transmits the high-risk allele to their offspring, respectively. The model further assumes that the three types of parents (AA, AB, and BB) in these nuclear families occur in the population with frequencies q2, 2q(1 -q), and (1 q)2.
Five models ofdisease transmission were tested against the general unrestricted model to identify the best model for these data. The "no major effect" or sporadic model assumes that baseline risk is not influenced by type; therefore, all persons have the same age-specific risk of prostate cancer. Mendelian models assume that a major locus with two alleles acting in codominant, dominant, or recessive fashion influences disease risk. An environmental model of nongenetically determined type-specific risk was also tested. Testing of dominant and recessive Mendelian models against the general unrestricted models and the codominant Mendelian model allowed the mode of inheritance to be determined. The recessive model was clearly rejected when compared to the general unrestricted model (model 4 vs. model 6; x2 = 19.6; df = 4; P < 0.001) and the codominant model (model 4 vs. model 2; x2 = 19.5; df = 1; P < 0.001). The hypothesis of a dominant disease-producing allele, however, was fully consistent with the distribution of prostate cancer in these families. The dominant model was defined by constraining homozygous and heterozygous carriers of the high-risk allele to have the same age-specific risk of prostate cancer that was higher than the risk for noncarriers (IAA = /AB > EBBS) Comparison with the general unrestricted model revealed that the dominant model provided a good fit to these data (model 3 vs. model 6; x2 = 3.10; df = 4; P = 0.55). Direct comparison of the dominant and codominant models showed that the codominant model did not provide a significant improvement in fit over the dominant model and that the dominant Mendelian model provided the best overall explanation for these data (model 3 vs. model 2; x2 = 3.03; df = 1;P= 0.08).
Because the proportional hazards analysis suggested heterogeneity in familial risk according to the proband's age at onset, a test for etiologic heterogeneity among the three previously defined subsets of families (proband's age at onset: <53 years, 53-65 years, and >65 years) was performed. Heterogeneity was assessed by comparing for the best-fitting autosomal dominant model, the sum of the -2 In L values obtained from separate analyses of each of the strata and the -2 In L value obtained from the entire group of families (34) . As seen in Table 5 , the log likelihoods summed over the three strata were not significantly different from the log likelihood of the entire group providing no evidence for heterogeneity.
Parameter estimates from the best-fitting autosomal dominant model were used to calculate genotype-specific penetrances. In both homozygous (AA) and heterozygous (AB) carriers, the high-risk allele was very penetrant (88% by age 85), whereas the cumulative risk for noncarriers (BB) was Genetics: Carter et al. (23) . Thus, the impact of hereditary prostate cancer in the population is the greatest at the younger ages that account for only a small proportion of the total disease occurrence. Despite the fact that only a small proportion of prostate cancer appears to be inherited in Mendelian fashion, genetic characterization of this subset of prostate cancer should provide significant insights into the molecular genetic mechanisms underlying prostatic tumorigenesis in general.
To our knowledge, this is the first report to describe a segregation analysis of prostate cancer and to report an autosomal dominant mode of inheritance of this cancer in a subset of families. Though (35) . Segregation analyses of these data have indicated that a rare autosomal dominant gene present in the population with frequencies ranging from 0.0006 to 0.0033 may account for breast cancer in 4 to 6%o of women (36, 37) . Furthermore, carriers of the putative high-risk allele were estimated to have an earlier onset of breast cancer than noncarriers (37) .
As described by Knudson (3, 38) 
